CVS vs DNTH · P/E 16, rev $402.07B vs rev $6.2M
CVS Health Corp (CVS) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CVS and DNTH stock pages for the full models.
Not investment advice.